Everyday champions: DMD parents and caregivers share stories of connection
A panel at the the CureDuchenne 2025 FUTURES National Conference shared insights from eight families impacted by DMD.
A panel at the the CureDuchenne 2025 FUTURES National Conference shared insights from eight families impacted by DMD.
While the therapy is promising, recent studies suggest that its benefits may be limited and carry potential risks.
Boys with DMD who received the treatment showed significantly less fat replacement and tissue damage in key leg muscles.
The analysis showed significant differences in the gut microbiota of individuals with DMD with and without an intellectual disability.
A new study found a protein lower in DMD carriers may serve as a useful biomarker in screening for the disease.
Intermittent prednisone increased the risk of cushingoid appearance, excess hair growth and high blood pressure in patients with DMD.
A new study found that blocking the protein EZH2 with an inhibitor drug improved muscle health and function in mice with DMD.
Boys with DMD have a harder time doing two things at once than their peers without the disease, negatively affecting everyday life.
A new study suggests that some female carriers of Duchenne muscular dystrophy (DMD) mutations experience symptoms and complications.